Wednesday, April 21, 2021
Home Clinical Data Management Important data points in Protocol for CRFs Creation (CDM Prospective):

Important data points in Protocol for CRFs Creation (CDM Prospective):

Reading of whole protocol is quite important and indispensable act but by keeping following points in mind, one can read protocol with more clarity and productivity.

  • Phase, Indication, Scope of study
  • Age, Sex, Demography and Race
  • Informed consent form
  • Inclusion Exclusion Criteria and Re-screening criteria.
  • Study design
  • Study arm
  • Study drug-Formulation, Dosing frequency
  • Dose reduction, Increase, interruption or Discontinuation criteria
  • Visit Schedule and Assessment (Please see the study arm related assessment if any)
  • Assessment to be performed in unscheduled visit or based on investigator judgement.
  • Labs and Image assessments
  • Drug dosing time points, Biomarker and PK data collection time (eg. Predose, post dose)
  • Adverse Event and SAE (serious adverse event) definition and reporting guidance and Severity criteria
  • Concomitant Medication and procedure reporting guidance
  • Medical History reporting guidance
  • Tumor Assessment criteria in oncology study (i.e RECIST)
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

four × five =

Most Popular

Chemotherapy-free treatment option to be offered to patients with England’s most common leukaemia

April 21, 2021: A brand new oral treatment for an incurable blood cancer has been recommended for NHS use by NICE.

GW Pharma receives EU approval for EPIDYOLEX® for treatment of seizures

April 20, 2021: "GW Pharmaceuticals, a world leader in discovering, developing and delivering regulatory approved cannabis-based medicinesannounces that the European Commission has...

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

April 16, 2021: "Amgen announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of...

JCVI issues new advice on COVID-19 vaccination for pregnant women

April 16, 2021: There have been no specific safety concerns identified with any brand of coronavirus (COVID-19) vaccines in relation to pregnancy.